Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01129245 · ClinicalTrials.gov registry record · NA
The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation
A NA study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01129245 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 20 participants.
The verdict
NCT01129245, a NA study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effect that Celebrex (a COX-2 inhibitor and non-steroidal anti-inflammatory drug) has on ovulation.
Interventions
- DRUG Placebo
- DRUG Celebrex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2009-09 |
| Est. Completion | 2011-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01129245
The ClinicalTrials.gov registry entry for NCT01129245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01129245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01129245 about?
NCT01129245 is a clinical study titled "The Effect of a Non-hormonal Cox-2 Inhibitor (Celebrex) on Ovulation". The purpose of this study is to assess the effect that Celebrex (a COX-2 inhibitor and non-steroidal anti-inflammatory drug) has on ovulation.
What is the current status of trial NCT01129245?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2009-09. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01129245?
The interventions under investigation include: Placebo (DRUG), Celebrex (DRUG).
Who is sponsoring clinical trial NCT01129245?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.